Vascular disease and infarcts

Published on 19/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2154 times

9

Vascular disease and infarcts

In the setting of rapidly evolving neurologic deficits, stroke is not synonymous with brain infarct, since the types of cerebrovascular disease that usually result in a stroke may involve infarction or intracranial hemorrhage (see Chapter 10). Infarct, a localized area of ischemic brain injury, should also be differentiated from global hypoxic-ischemic brain injury (see Chapter 8). Stroke has been defined by the WHO as ‘rapidly developing clinical signs of a focal (or global) disturbance of cerebral function, lasting more than 24 hours or leading to death and with no apparent cause other than that of vascular origin’. Stroke ranks as the second most common single cause of death in the developed world.

The definition of brain infarct or infarction (the pathophysiological process that results in an infarct) has undergone numerous refinements over the last 30years as the result of advances in neuroimaging. The goal of neuroimaging is to differentiate permanent/irreversible brain tissue injury from viable tissue at risk for injury, the latter being viewed as tissue that could be salvaged as a stroke evolves over minutes or hours. Increasingly, both clinicians and neuroscientists think of the cerebral vasculature together with its surrounding parenchymal components – the ‘neurovascular unit’. Cellular elements of the neurovascular unit have critical metabolic interrelationships and encompass components of the cerebral capillary and arteriolar walls, as well as surrounding glia and neurons. Function or dysfunction of the neurovascular unit influences the capacity of the CNS to repair itself after stroke.

Transient ischemic attack (TIA) is viewed by clinicians as a warning sign of impending infarction (less commonly cerebral hemorrhage). Therefore, since 2009, TIA has been defined as ‘a brief or transient episode of neurologic dysfunction caused by focal brain, spinal cord or retinal ischemia, with clinical symptoms typically lasting less than one hour and without evidence of acute infarction’.

To place these concepts in a more practical context, brain infarcts can be caused by:

image STROKE TERMINOLOGY

The term ‘stroke’ includes:

Acute stroke

image Infarction describes rapidly developing focal clinical signs of CNS (and/or retinal) dysfunction due to ischemia, and either radiologic evidence of CNS (and/or retinal) ischemia in a defined vascular distribution, or symptoms and signs of CNS dysfunction persisting for at least 24 hours, with exclusion of non-ischemic etiologies.

image Intracerebral (parenchymal) hemorrhage describes a focal collection of blood within brain parenchyma (possibly extending to the ventricular system) on neuroimaging or at necropsy, which is not due to trauma, hemorrhagic conversion of an infarct, or cerebral venous (sinus) thrombosis.

image Subarachnoid hemorrhage (SAH) describes bleeding into the subarachnoid space (SAS) that is detected on neuroimaging, by lumbar puncture, or at necropsy, and which is not due to trauma or hemorrhagic conversion of an infarct.

image Cerebral venous thrombosis (CVT) describes infarction or hemorrhage in the CNS, evident on neuroimaging and due to thrombosis of a cerebral vein or venous sinus.

image GENETICS OF ISCHEMIC CEREBROVASCULAR DISEASE

Brain infarcts occur as one of many systemic manifestations in various hereditary disorders.

Marfan syndrome

Population-based studies of stroke in defined geographic regions (e.g. Iceland) indicate:

image ATHEROSCLEROSIS AND STROKE

image Atherosclerotic stroke is usually associated with documented risk factors for atherosclerosis and/or a family history of atherosclerosis (often premature). Patients may manifest (simultaneously, before, or after) coronary artery or peripheral vascular disease.

image TIA is a common presentation of stroke; a patient experiencing a TIA is at high risk for developing a completed stroke in the near future.

image The focal neurologic deficit is referable to the artery involved by unstable atheroma, e.g. a right ICA atheromatous plaque may produce transient or episodic right monocular blindness (amaurosis fugax) and left hemiparesis. Platelet-fibrin emboli or atheroemboli (Hollenhorst plaques) can sometimes be visualized by funduscopic examination.

image Atherosclerotic stroke results from inadequate perfusion of a brain territory due either to arterial occlusion or dislodgement and embolization of atheromatous or platelet-fibrin material.

image The role of intraplaque hemorrhage or plaque rupture in stroke pathogenesis (e.g. at the carotid bifurcation) is demonstrated in some autopsy studies.

image Thrombosis usually originates extracranially, at the carotid artery bifurcation or within the intraosseous portion of the vertebral artery, though thrombus can propagate distally to involve intracranial vessels. Less often, an atherosclerotic intracranial artery is the site of primary thrombosis.

image Atherosclerotic plaques examined less than 60 days after an ischemic ‘event’ show more macrophage infiltration after a stroke than after a TIA. Macrophage content declines over time in plaques associated with strokes, but not in plaques associated with TIAs.

image EPIDEMIOLOGIC ASPECTS OF STROKE

image In each successive decade beyond the age of 55years, the stroke rate doubles in both men and women; incidence for individuals aged 45–54years is ~100/100 000, increasing to >1800/100 000 for those aged over 85years.

image In the USA, there are approximately 500 000 new strokes annually.

image In 2005, stroke prevalence was 5.8 million among adults aged >20years of age; age-specific prevalence rises from 1–2% to >10% from 45–85years of age.

image Stroke causes ~150 000 deaths/year (USA), although this figure has been declining, possibly as the result of stroke risk factor modification.

image In the USA, stroke-related death rates vary widely between states: 31–42/100 000 in Arizona, New Mexico, Colorado, New England versus 52–61/100 000 in Oregon, Idaho and the south-eastern states.

image Major risk factors for stroke (in addition to those for atherosclerosis) are: oral contraceptive use; some hematologic disorders (e.g. sickle cell disease, polycythemia); some inherited coagulopathies, and various cardiac/vascular diseases.

image In most USA studies, brain infarction is approximately 10 times more common than brain hemorrhage. This ratio is lower in some European and virtually all Japanese studies; some series from Asia have found hemorrhage to be almost as common as infarction.

image The annual financial burden of stroke in the USA is $65 billion ($219 billion for cancer; $174 billion for diabetes); acute (hospital) care is required by 45–50%, nursing home placement is required by 17–20%, and long-term ambulatory care is required by 35%.

LARGE ARTERIAL DISEASE

ATHEROSCLEROSIS

Atherosclerosis is by far the leading systemic vasculopathy to result in brain infarcts, especially in older patients. Risk factors for and the pathogenesis of atherosclerosis are presumed to be similar, regardless of vascular territory, e.g. coronary, cerebral, mesenteric, and limb arteries. Modifiable risk factors include hypertension, cigarette smoking, hyperlipidemia/hyperlipoproteinemia, and diabetes.

Atherosclerosis can affect both intracranial and extracranial large arteries, and may extend into leptomeningeal arteries. When extracranial (cervical) atherosclerosis (e.g. at the carotid bifurcation) is the proximate cause of cerebral ischemia, a measure of prophylaxis against a large infarct may be achieved through carotid endarterectomy. In recent years, stenting of atherosclerotic arteries has been used as a less invasive procedure than endarterectomy. The benefits of carotid endarterectomy have been clearly established in clinical trials; symptomatic patients with 50–99% stenosis benefit significantly in a comparison with the best medical treatment.

MACROSCOPIC APPEARANCES

The severity of atherosclerosis can vary significantly in different arteries (e.g. severe basilar artery involvement may accompany less prominent MCA involvement). The degree and extent of aortic or coronary atherosclerosis do not predict its severity in the intracranial basal cerebral vasculature, i.e. compartments of the circle of Willis. Atheroma is often most severe at the origins of the vertebral arteries and carotid bifurcation (Figs 9.1, 9.2). Intracranial atherosclerosis is most severe in major branches of the circle of Willis and vertebrobasilar system (Fig. 9.3). Atheroma in distal arterial branches is more common in Asian and African-American subjects. The extent and topography of atherosclerosis in the basal vessels are often best documented by removing the circle of Willis from the fixed brain (Fig. 9.3b). In such a specimen from a subject with severe atherosclerosis, decalcification prior to histologic examination is recommended. Carotid endarterectomy specimens from individuals with TIA or threatened ischemic stroke are often submitted for histologic examination; extent and severity of atheroma within plaques, as well as the presence of plaque ulceration, necrosis and thrombus adherent to intima must be assessed (Fig. 9.2).

MICROSCOPIC APPEARANCES

Histopathologic features of atheroma are best highlighted with stains that differentiate elastica, fibrous tissue, and smooth muscle (e.g. elastica van Gieson). Immunohistochemistry (IHC) using primary antibodies to vascular smooth muscle actin, endothelium (Factor 8, lectins), and macrophages may be helpful. Fibromuscular intimal hyperplasia with an intact endothelium and variable narrowing of the vascular lumen is noted in ‘early’ and asymptomatic vascular lesions, and often discovered incidentally at necropsy (Fig. 9.4). Complicated plaques show cholesterol clefts and prominent lipid-/hemosiderin-laden macrophages and may be heavily calcified. There is usually significant narrowing of the arterial vessel lumen, sometimes in association with ulceration and overlying mural or occlusive thrombus (Fig. 9.5). Immunohistochemistry (IHC) using primary antibodies to smooth muscle actin often demonstrates a thick smooth muscle cell ‘cap’ over a lipid-rich subendothelial plaque. It is quite rare for even severely narrowed segments of the circle of Willis to show plaque ulceration, in contrast to the frequency of this phenomenon in ICA endarterectomy specimens. Severely atherosclerotic arterial segments, especially in the basilar artery may show ectasia or even a fusiform aneurysm.

The distal circulation, both meningeal and parenchymal arteries, may show atherosclerotic changes or deposits of platelet-fibrin material (Fig. 9.6). Rarely, examination of an autopsy brain specimen from an individual with severe atherosclerosis may yield the finding of numerous atheroemboli within infarcted regions (Fig. 9.7).

image THE AUTOPSY OF A STROKE PATIENT

Especially important for infarction/ischemic stroke

image Assess the patency of major neck arteries (carotid/vertebral) by injecting water at their origins and monitoring flow into the cranial cavity after brain removal.

image Carefully examine the heart, looking particularly for:

image Look for old/recent infarcts in other organs, which may suggest a source of embolism.

image If there is minimal evidence of macro/microvascular disease, and cardiac examination is normal, consider hematologic disorders (e.g. antiphospholipid syndrome, platelet abnormalities, coagulopathies). These must be sought in non-neuropathologic components of the autopsy and in antemortem laboratory results or through toxicology specimens to assess a possible role for recreational drugs.

Especially important for hemorrhage:

image In the medical history and general autopsy, seek evidence of disease that may be of etiologic significance, even though this may not be discovered in many individuals:

image When a hematoma is documented at the time of brain removal, the prosector must establish:

image When a hematoma is first discovered at the time of brain cutting (i.e. it was clinically unsuspected), sample surrounding tissues generously in order to document microvascular disease or remnants of hemangioma/neoplasm. Also evaluate reactive changes in adjacent brain to provide an estimate of its age.

image For special studies regarding the evaluation of evacuated intracerebral blood clot, see Chapter 10.

FIBROMUSCULAR DYSPLASIA (FMD)

This entity is much less common than atherosclerosis. It is best characterized as an idiopathic, segmental, non-inflammatory, non-atherosclerotic vascular disease affecting renal and carotid arteries (most commonly), though it may occur in any artery. Some studies suggest a relationship to segmental arterial mediolysis (a disorder in which smooth muscle cells in the outer part of the tunica media undergo vacuolation and lysis). This occurs mainly in splanchnic and coronary arteries and may be due to vasospasm of unknown etiology.

FMD of the renal arteries is estimated to occur in 1% of adult necropsies; vertebral and carotid arteries are affected in 25% of reported cases, carotid much more often than vertebral. Carotid artery involvement is bilateral in over half of affected patients.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Several pathologically distinct subtypes of FMD are described:

Two rare variants that account for no more than 1–2% of cases are medial and adventitial (periarterial) FMD.

Histologic findings that are characteristic include fibrosis, non-atherosclerotic smooth muscle cell hyperplasia or thinning, destruction of the internal elastic lamina, negligible inflammation, absence of macrophages, and generalized disorganization of arterial wall components (Fig. 9.8).

MOYAMOYA DISEASE

This is a rare idiopathic condition characterized by progressive stenosis and eventual occlusion of basal intracranial arteries. There is compensatory often dramatic dilatation of lenticulostriate arteries that produces a characteristic ‘puff of smoke’ appearance on angiography. Moyamoya disease was initially described in Japan, but is now well documented in other populations, including Caucasian and African-American, though it remains most common in those of Asian descent. Thrombotic lesions in branches of the circle of Willis implicate abnormal thrombogenesis in the pathogenesis of moyamoya; regions of intimal thickening may represent organizing thrombi.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Arterial branches of the circle of Willis show thrombotic lesions in over 50% of patients. Those most commonly affected are the ICA, posterior communicating and posterior cerebral arteries. Severely stenotic non-complicated atherosclerosis, with intimal fibromuscular hyperplasia, but negligible lipid, cholesterol, inflammation, or disruption of the elastica is found (Fig. 9.9). Platelet-fibrin thrombi in various stages of organization are often seen at the intimal surface.

ARTERIAL DISSECTION

This is rare and tends to affect young and middle-aged adults. The dissection (Fig. 9.10) is usually spontaneous, but can be initiated by blunt trauma, often quite mild (e.g. neck injury in a motor vehicle accident or chiropractic manipulation of the neck). The dissection may involve extracranial or intracranial parts of the vertebral artery (more common in women) or carotid artery (more common in men). An intimal tear leads to a medial or subendothelial hematoma. The expanding hematoma may occlude the arterial lumen, usually producing infarction of CNS tissue, less commonly hemorrhage. Dissection of intracranial arteries, especially the vertebral artery, may rarely extend through the adventitia, producing subarachnoid hemorrhage. Dissection of intracranial arteries is likely to become more common as aggressive endovascular revascularization procedures (e.g. thromboembolectomy after ischemic stroke) become more widely utilized in clinical neurologic practice (Fig. 9.11).

Diagnosis is usually by angiography, which may show a double lumen, focal vessel wall irregularity, and/or a fusiform dilatation. As with most aspects of stroke, neuroimaging shows that many patients with a dissection have minimal brain infarction and can make an excellent recovery; those that have a fatal dissection represent a highly selected population.

HUMAN IMMUNODEFICIENCY VIRUS (HIV)-ASSOCIATED STROKE

When a stroke occurs in an HIV-infected patient, it may be difficult to ascertain its precise cause. Many of the opportunistic infections and CNS lymphomas seen in such patients may cause, mimic (clinically and by neuroimaging), or contribute to cerebrovascular disease; well known for doing this are cytomegalovirus (CMV), which may infect cells in vessel walls, and varicella-zoster virus (VZV) infections, toxoplasmosis, aspergillosis, and tuberculosis. Frequently, these agents cause extensive, sometimes hemorrhagic, necrosis that can resemble a spontaneous hematoma. One study found evidence of cerebrovascular disease in 5–10% of necropsies carried out on AIDS patients. As many as 20–25% of children with AIDS have evidence of cerebral hemorrhage or infarcts, in roughly equal proportions. Rarely, children with longstanding AIDS develop an aneurysmal arteriopathy of vessels on the circle of Willis.

Pathologies commonly seen in HIV-infected/AIDS patients predispose to embolic infarcts; these are non-bacterial thrombotic/marantic endocarditis, infective endocarditis, or are the result of HIV-associated cardiomyopathy. HIV ‘vasculitis and vasculopathy’ (both conditions are fairly rare, not well characterized pathologically, and lack specific features other than hyalinization and thickening of vessel walls), recreational drug-associated vasculopathy (amphetamines or cocaine), infections or hypercoagulable states (protein S deficiency or antiphospholipid antibody syndrome), or hyperviscosity syndrome may all, individually or in combination, cause ischemic infarcts. Hemorrhagic stroke may result from thrombocytopenia, intracranial CNS lymphoma, or infections, amphetamine or cocaine vasculopathy, or a ruptured infective (mycotic) aneurysm.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

HIV-associated ‘vasculopathy’ has been described as showing non-specific features, including intimal fibromuscular hyperplasia, fragmentation of the internal elastic lamina, and sometimes aneurysmal dilatation of vessel walls, a pathology consistent with ‘healed arteritis’ (Fig. 9.12). HIV-infected individuals (including those responsive to combined retroviral therapy) may be at risk for accelerated atherosclerosis, though factors responsible for this are unclear. Brain parenchymal arteriosclerotic change has also been observed in HIV-infected individuals that develop cerebral microinfarcts. HIV-1 has been demonstrated immunohistochemically in affected vessel walls (possibly within the cytoplasm of macrophages), but its pathogenic role in this location is unclear.

image ANTIPHOSPHOLIPID ANTIBODY (APLA) SYNDROME

image APLAs are associated with risk of thrombosis in both arterial and venous systems.

image APLAs of most clinical importance are the lupus anticoagulants and those that target a complex of cardiolipin and β2-glycoprotein; 5% of the population have APLAs.

image Decreased levels of APLAs are a relatively common, usually transient, finding during or after viral infection or in individuals taking chlorpromazine, but probably do not carry increased risk of thrombotic disease.

image Up to a half of patients with SLE and some patients with other autoimmune diseases have high levels of APLAs and are at risk of thrombotic diseases, including recurrent (early adulthood) ischemic strokes from arterial/venous thrombosis.

image Other manifestations of hypercoagulability in those with APLAs may include optic atrophy, systemic (e.g. myocardial) infarcts, recurrent fetal loss (associated with placental microthrombi) and livedo reticularis; though any organ may be affected, CNS manifestations are the most common.

image Most SLE patients in whom thrombotic cerebrovascular disease occurs have high titers of APLAs.

image The mainstay of treatment is warfarin or other forms of anticoagulation.

image Sneddon syndrome is the association of livedo reticularis and strokes with APLAs.

CEREBROVASCULAR DISEASE ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODY

Antibodies that bind phospholipids (APLAs) are associated with various thromboembolic syndromes, including recurrent venous and arterial thrombosis. Nearly 20% of APLA-related thromboses affect the cerebral circulation. Anticardiolipin antibodies are an independent risk factor for initial ischemic stroke. These antibodies are detected by enzyme-linked immunosorbent assay (ELISA) using cardiolipin as the antigen, or by demonstrating lupus anticoagulant activity.

ANGIITIS AND VASCULITIS AFFECTING LARGE ARTERIES

Most forms of angiitis involving the CNS affect the microvasculature. The only two diseases affecting major arteries supplying the CNS are:

GIANT CELL ARTERITIS (GCA)

GCA involves large- and medium-sized arteries, including the carotid and vertebral arteries and their major branches. Most clinical impact is on the eye and/or brain. Devastating infarcts may result from MCA or ACA occlusion.

The etiology of GCA remains unknown, but it could represent an anomalous granulomatous inflammatory response to the elastic component of arterial walls or to an (as yet) unidentified microbial pathogen. Humoral immunity might be involved in its pathogenesis. GCA responds rapidly and well to treatment with steroids.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

GCA is characterized by widespread granulomatous inflammation within arterial walls, sometimes causing cerebral infarction. Commonly affected vessels include the aorta and coronary arteries, cerebral arteries, and other head or neck arteries, including the central retinal artery (Fig. 9.13). Multinucleated giant cells are usually a prominent feature of the inflammatory infiltrate, and their cytoplasm may contain fragments of elastica. The polyclonal and polymorphous lymphocytic infiltrate seen within affected arterial walls includes mainly T-cells, with CD4 (helper) cells exceeding CD8 (suppressor) cells, thus implicating cellular immunity in the disease.

PATHOLOGIC FINDINGS AFTER ENDOVASCULAR INTERVENTIONS

Many cerebrovascular diseases are now treated using endovascular, rather than neurosurgical, approaches or a combination of endovascular and neurosurgical techniques. Examples of lesions treated by endovascular intervention include AVMs, berry/saccular aneurysms (by ‘coiling’ or injection of prothrombotic material into the aneurysm’s dome), thrombi/thromboemboli (with tissue plasminogen activator or thromboembolectomy, e.g. MERCI or PENUMBRA devices).

The various procedures may result in idiosyncratic surgical or autopsy specimens:

image Thrombectomy specimens (extracted from occluded arteries) generally contain aggregates of platelets/fibrin, linear collections of leukocytes, and erythrocyte-rich regions, but cholesterol clefts or ‘crystals’ (indicating probable atheroemboli) are notably absent. Unexpected findings in such specimens have included mycotic emboli and fragments of atheroma with attached arterial intima. Early endothelialization may be seen within and over the thrombus.

image Patients that come to autopsy after unsuccessful thromboembolectomy or post-treatment complications usually show bland/hemorrhagic infarcts, thrombi (residual or post-treatment) and subintimal dissection (Figs 9.14, 9.15).

image

9.14 Endovascular intervention.
These images and those in Fig. 9.15 are from patients who underwent autopsy after thromboembolectomy using a mechanical retriever device. (a) Severely atherosclerotic circle of Willis dissected from base of brain. (b,c) Parallel sections from moderately atherosclerotic left MCA bifurcation. (c) Immunohistochemistry with anti-smooth muscle actin antibody to highlight smooth muscle cell hyperplasia. (d) section of basilar artery immunostained with anti-CD68 antibody to highlight dense accumulation of macrophages in the plaque. (e,f) Adjacent sections through left MCA. (f) Immunohistochemistry with anti-smooth muscle actin antibody.

image

9.15 Endovascular intervention.
These images and those in Fig. 9.14 are from patients who underwent autopsy after thromboembolectomy using a mechanical retriever device. (a,b) Coronal slices of fixed brain from patient that expired 38 days after attempted thromboembolectomy. Note large right MCA territory infarct undergoing liquefactive necrosis (arrows). (c) ‘Saddle’ thromboembolus at right MCA bifurcation. (d,e) Representative cross-sections of right MCA showing a fairly well-organized thromboembolus in a relatively non-atherosclerotic artery. (e) Immunohistochemistry with anti-smooth muscle actin antibody

image Patients that receive intra-arterial/intravenous TPA injection (usually within 3–6 hours of symptom onset) may develop intraparenchymal hemorrhage; the latter is especially common in elderly individuals that have advanced amyloid angiopathy. The presence of cognitive impairment or dementia in a patient that then develops an ischemic infarct is generally regarded as an absolute contraindication to TPA administration.

image Even subjects that have not undergone a therapeutic endovascular intervention, but have had intra-arterial procedures (e.g. catheter angiography) may have intravascular foreign materials (e.g. from catheter sheath coverings) that are associated with a brisk foreign body giant cell reaction and brain ischemia (Fig. 9.16). Such materials may rarely be seen in brain biopsies from encephalopathic patients with a past history of many angiographic/endovascular procedures.

SMALL VESSEL DISEASE (MICROANGIOPATHY)

This is arbitrarily defined as disease affecting arteries with a transverse diameter of ≤300 μm, predominantly arterioles, but also venules and capillaries. The most common cerebral microvasculopathies or microangiopathies are:

These conditions are commonly associated with intraparenchymal brain hemorrhage. Arteriosclerosis and lipohyalinosis are also associated with cerebral infarcts, especially lacunar infarcts. CAA is associated with large parenchymal hemorrhages and microinfarcts (some of which may represent ‘healed/healing’ microhemorrhages). Given the common association between CAA and Alzheimer disease, one mechanism contributing to cognitive impairment in AD patients may thus be widespread microinfarcts, at least in a subgroup of AD subjects with especially severe CAA. By contrast, the microangiopathies considered below are almost exclusively associated with ischemic rather than hemorrhagic lesions.

PRIMARY ANGIITIS OF THE CNS (PACNS)

PACNS is almost certainly multifactorial in etiology. It may represent an unusual response to autoantigens or viral infection; varicella zoster infection has been implicated in some cases. Males are more commonly affected than females, and diagnosis is usually in the 5th or 6th decade. Patients may present with headache, encephalopathy, myelopathy, or the range of neurologic symptoms and signs associated with focal ischemic or hemorrhagic stroke.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

In approximately 20% of PACNS cases, the pathology may be similar to that of systemic giant cell (granulomatous) angiitis, comprising widespread granulomatous inflammation of leptomeningeal and parenchymal blood vessels and occasionally including branches of the circle of Willis (it is therefore not exclusively a microangiopathy). Giant cells may be present within granulomas, admixed with abundant lymphocytes and plasma cells, but conversely may be a negligible component of the pathology. Focal fibrinoid necrosis of affected vessel walls is common (Figs 9.18, 9.19). Rarely, PACNS can affect the spinal cord predominantly or exclusively.

In a biopsy, the presence of an angiocentric, mildly or moderately atypical lymphoid infiltrate always invokes the differential diagnosis of primary CNS lymphoma, especially well-differentiated plasmacytoid variants. The finding of associated fibrinoid necrosis of vessel walls or thrombosis tips the balance in favor of vasculitis, whereas cytologic pleomorphism and a high growth fraction, as indicated by frequent mitoses or high Ki-67 immunolabeling, favors lymphoma.

Severe granulomatous inflammation, presenting as angiitis, is occasionally associated with advanced CAA (Fig. 9.20). Some have designated this entity as amyloid-b-related angiitis (ABRA). Affected patients present and progress differently to those with AD-related CAA, usually showing a more rapid progression of cognitive impairment and a partial response to anti-inflammatory agents. The diagnostic lesson is that, when severe angiitis is encountered in the brain of an elderly individual, associated Aβ CAA should be suspected and appropriately investigated.

ANGIITIS DUE TO MISCELLANEOUS VASCULITIDES

MACROSCOPIC AND MICROSCOPIC APPEARANCES

These vary as follows:

image Polyarteritis nodosa is a multifactorial panarteritis that causes destruction of the elastica and affects small and medium-sized arteries. The acute phase is characterized by neutrophil infiltration of the vessel wall and fibrinoid necrosis. The chronic/healing phase is characterized by vascular fibrosis. End-organ damage results from thrombosis, ischemia and infarction.

image Allergic angiitis and granulomatosis (Churg–Strauss syndrome) is an allergic condition (diathesis) with consistent lung involvement and eosinophilia. Fibrinoid necrosis and eosinophilic granulomatous inflammation affect small and medium-sized arteries, capillaries and venules.

image Wegener’s granulomatosis is characterized by granulomatous vasculitis of the respiratory tract with or without glomerulonephritis. It results in fibrinoid necrosis, the presence of inflammatory cells in small arteries and veins, and granulomas containing prominent giant cells.

image Lymphomatoid granulomatosis typically involves the lungs, but other organs, including the CNS, can be affected. It is characterized by angiodestructive lesions of parenchymal arteries and arterioles, in which a highly polymorphous transmural infiltrate of atypical leukocytes is almost always combined with fibrinoid necrosis. The disease is now thought in most cases to be a form of diffuse large B cell lymphoma, usually driven by EBV infection and with a prominent and somewhat atypical T cell infiltrate (Figs 9.21, 9.22). Rare angiotropic lymphomas of T-cell or Ki-1 anaplastic large cell type have been reported.

The CNS may also be involved in microscopic polyangiitis (MPA) and Behçet’s disease, as well as connective tissue disorders (SLE, Sjögren syndrome, rheumatoid arthritis, and mixed connective tissue disorders).

Additionally, angiitis of the CNS may be a complication of various infections, including HIV-1 (and opportunistic viral pathogens that commonly complicate AIDS, e.g. CMV, VZV), syphilis, Borrelia burgdorferi, Mycobacterium tuberculosis, and various fungi. Meningoencephalitis of any etiology, but especially when suppurative, may involve meningeal blood vessels, leading to their walls becoming inflamed and/or necrotic, with resultant thrombosis and ischemic necrosis of adjacent tissue supplied by those vessels. Reports are emerging of CNS vasculitis associated with hepatitis C virus infection, not associated with cryoglobulinemia.

MICROVASCULOPATHIES ASSOCIATED WITH DEMENTIA

‘Pure’ ischemic-vascular dementia (IVD), with negligible Alzheimer disease pathology, is also known as multi-infarct dementia, is quite rare, and has varied neuropathologic substrates. These include large infarcts and a combination of cystic, lacunar and micro-infarcts throughout the brain, each associated with different forms of cerebrovascular disease (Fig. 9.23). Infarction may result from basal or cervical (carotid/vertebral) atherosclerosis and intraparenchymal microvascular disease. Hippocampal injury that manifests as small glial scars or mimics the hippocampal sclerosis seen in temporal lobe epilepsy may also be evident. ‘Sub-infarctive’ ischemic lesions, e.g. within subcortical white matter, may contribute to IVD, but their etiology is poorly characterized. Occasionally, white matter arteries show adventitial fibrosis and enlarged perivascular spaces, though surrounding brain tissue can be remarkably unaffected in terms of reactive change; mild proliferation of microglia and astrocytes may be one manifestation of such borderline ischemia.

Though dementia may result from widespread arteriosclerosis or CAA throughout the brain, four distinct entities will be considered in more detail. Recall that CAA is a common age-associated microangiopathy and is one of the microscopic features of AD, often associated with brain hemorrhages and widespread cerebral microinfarcts.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

There is diffuse, often poorly demarcated (unless lacunes are present) white matter cavitation and softening; well-defined foci of necrosis may be seen (Fig. 9.24). Microscopic sections confirm infarction and reactive change. Microvascular changes are usually those of arteriosclerosis/lipohyalinosis, with prominent ‘onion skin’ type thickening of affected arteries. Microscopy also reveals astrocytic gliosis, microglial activation and an inflammatory response (Fig. 9.24). Chronic lympho-histiocytic inflammation may sometimes be seen in thickened arterial walls.

image MISCELLANEOUS MICROANGIOPATHIES

Familial

COL4A1 vasculopathy

Small cerebral arteries are affected causing cerebral hemorrhage (including microbleeds) and lacunar infarcts. Mutations in COL4A1 occur in several disorders:

MACROSCOPIC AND MICROSCOPIC APPEARANCES

These include cortical and subcortical atrophy with myelin loss, astrocytosis and small foci of cystic encephalomalacia in the subcortical white matter (Fig. 9.25). Small arteries show fibrosis and replacement of smooth muscle cells in the media by eosinophilic, periodic acid-Schiff (PAS)-positive, Congo red-negative, granular material (Fig. 9.26). Ultrastructural studies reveal compact electron-dense GOM around remaining smooth muscle cells (Fig. 9.25).

Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) (MAEDA syndrome)

Clinically, there is presenile dementia (age of onset 29–50years), together with alopecia and spondylosis. Pathologically, there is an ischemic non-hypertensive microangiopathy, with white matter infarcts. The arterial changes resemble non-complicated atherosclerosis with intimal hyperplasia and affect slightly larger blood vessels than those involved in CADASIL (Table 9.1). Arteriolar sclerotic changes are also noted (Fig. 9.26).

Cerebroretinal vasculopathies and hereditary endotheliopathy with retinopathy nephropathy and stroke (HERNS)

These may be similar or identical entities. HERNS is a multi-system disorder that has an IVD-like component. Only one necropsy has been performed on a patient with HERNS. Cavitation was evident in the subcortical white matter, extending into the basal ganglia (Fig. 9.27). Other features were large areas of ischemic necrosis and small unusual angiomatoid formations surrounded by calcifications (Fig. 9.28).

MISCELLANEOUS (SPORADIC) MICROANGIOPATHIES

Systemic lupus erythematosus is more commonly associated with brain infarcts than hemorrhages. Stroke may result from emboli associated with Libman–Sacks endocarditis or hypertension associated with renal disease. Microinfarcts and small hemorrhages may be found in affected brains, but true vasculitis is rarely observed. Hyaline change in the walls of thickened arteries is, however, sometimes associated with perivascular lymphocytes (Fig. 9.29).

Thrombotic thrombocytopenic purpura preferentially involves gray matter. An interaction of platelets with platelet-aggregating factor or unusual multimers of factor VIII:von Willebrand factor may cause abnormal platelet agglutination resulting in microvascular thrombi and end-organ (including cerebral) ischemia (Fig. 9.30).

Siderocalcinosis and ferruginization are the encrustation of microvessels with calcium and iron respectively. Arteries and arterioles, particularly those in the basal ganglia and endplate region/dentate fascia of the hippocampus, are affected. The encrustation is accompanied by variable collagenous thickening of the intima and narrowing of the vascular lumen (Fig. 9.31). Capillaries may also be affected (Fig. 9.32). In a few elderly people, some of whom have hypoparathyroidism, many small and medium-sized blood vessels in the basal ganglia and cerebellum become calcified. This vascular change is also frequently noted in the CNS of patients with AIDS and can occur in mitochondrial encephalopathies.

EMBOLIC DISEASES (STROKE)

An embolic infarct may occur when any solid/particulate material:

The resultant infarct is usually:

image clinically abrupt in onset due to sudden cessation of blood flow

image hemorrhagic, possibly because of dissolution of the embolus with re-establishment of blood flow into necrotic tissue or into viable tissue in which blood vessel walls have been rendered necrotic (Figs 9.33, 9.34).

The differential diagnosis of embolic stroke includes:

image SOURCES OF BRAIN AND SPINAL CORD EMBOLI

Heart

Emboli associated with cardiac lesions are an important cause of ischemic stroke, especially in young people who are relatively free of atherosclerosis. Principal sources of cardiogenic emboli are:

image Thrombus originating in the non-contractile left atrium of a patient with atrial fibrillation.

image Mural thrombi from endocardial surface of a hypokinetic left ventricular wall segment, in association with cardiomyopathy, myocardial infarct, or ventricular aneurysm.

image Endocarditis, either infective (e.g. in association with a prosthetic valve or after rheumatic fever) or non-bacterial thrombotic (marantic) endocarditis; resultant emboli may be either septic (Fig. 9.35) or composed of platelets/fibrin (Fig. 9.36).

image Platelet-fibrin emboli (variably calcified) from miscellaneous valve lesions such as rheumatic valvular disease, mitral valve prolapse, and calcific aortic sclerosis.

image Fragments of valvular material that break away during cardiothoracic surgical or endovascular therapeutic procedures (Fig. 9.37, and see Fig. 9.40).

image Paradoxical embolus in association with a right-to-left shunt.

image Cardiac neoplasms, especially cardiac myxoma.

Iatrogenic causes

CEREBRAL VENOUS (SINUS) THROMBOSIS (CVT)

CVT is a significantly less common cause of stroke than arterial or embolic disease, though necropsy series probably underestimate its true incidence. Infection is becoming a relatively less important causal factor. Cavernous sinus thrombosis is the most common example of septic venous thrombosis affecting the CNS.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Macroscopic findings depend upon the interval between onset of CVT and death. The most consistent feature is severe and extensive hemorrhagic necrosis in the brain, often with evolution into parenchymal hematomas (Fig. 9.43). The hemorrhagic infarcts may be indistinguishable from those caused by emboli, except that they are not usually defined by the boundaries of a specific arterial territory. The thrombosed sinus is usually engorged (Fig. 9.44).

Histologic sections show hemorrhagic necrosis (Fig. 9.43). If there is a septic component, microorganisms may be demonstrated with appropriate stains, and inflammatory cells are abundant in the thrombus.

image HEMATOLOGIC DISORDERS (INCLUDING INHERITED COAGULOPATHIES) INCREASING THE RISK OF DEVELOPING BRAIN INFARCTS

These disorders are relatively uncommon, but should be considered in children and young adults with stroke, especially if there is a history of previous venous or arterial thrombotic disease involving tissues or organs outside the CNS.

image Hematologic disorders cause 1–2% of arterial ischemic stroke and include myeloproliferative disorders, multiple myeloma, lymphoma, chronic lymphocytic leukemia, disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, APL antibody syndrome, and factor V mutation associated with lupus anticoagulant.

image Principal inherited coagulation disorders linked to brain infarcts include:

• Protein C deficiency. This increases the risk of arterial and venous brain infarction, especially if combined with oral contraceptive use or other prothrombotic conditions (e.g. protein S deficiency). The defective gene maps to chromosome 2q13–14.

• Factor V Leiden mutation (R506Q). This mutation prevents inactivation of factor V by protein C (also known as activated protein C resistance, APC-R). Clinically, there is a risk of developing systemic venous thromboses/thromboemboli. Rarely, factor V Leiden mutation is found in children with brain infarction.

• Protein S deficiency. This is an occasional finding in children or young adults with brain infarcts, and the defective gene maps to 3q11.

• Antithrombin III abnormalities. Deficient or defective antithrombin III is associated with venous thrombosis and is a rare cause of brain infarction.

• Carbohydrate-deficient glycoprotein synthase type I. This rare enzyme deficiency affects synthesis of many coagulation factors and their inhibitors, substantially increasing the risk of venous thromboses and brain infarcts.

CNS INFARCTION

MACROSCOPIC APPEARANCES

The macroscopic appearances of a brain or spinal cord infarct at necropsy depend upon the interval between onset of stroke and death. Evolution of these gross appearances corresponds approximately to a sequence of microscopic abnormalities, though the dating of infarcts using macroscopic and microscopic criteria is relatively imprecise. Any pathologist attempting to establish the clinicopathologic timeline of an infarct must also take into account sensitive neuroimaging data.

In clinicopathologic studies of brain ischemia, such infarcts are often arbitrarily described as being:

More than one type of lesion may be found, and any of the three types may have a significant hemorrhagic component, though it may be argued that a hemorrhagic lacune or microinfarct may actually be the result of a bleed, rather than a focus of ischemia.

Acute infarction

An infarct that has occurred from 0–8 hours before a patient’s death is almost always undetectable macroscopically, and even microscopic abnormalities may be minimal.

Changes that develop within 8–36 hours include slight blurring of the gray/white matter interface, dusky discoloration of gray matter and slight softening of the tissue on palpation. These changes may be relatively easy to detect, especially if confined to the territory of a major cerebral artery (Fig. 9.45).

Subacute infarction

Infarction with an antemortem time frame of 2–4 days appears as distinct softening, with blurring of the gray/white matter junction and dusky gray discoloration of brain tissue. At this stage, the most telling abnormality is cerebral edema (Figs 9.46, 9.47).

Chronic infarction

image Stage I: As edema subsides antemortem, the region of infarction starts to undergo liquefactive necrosis, eventually leading to cavitation (Fig. 9.48).

image Stage II: An old infarct (older than several months) appears as a cystic cavity within the brain substance and is surrounded by atrophic brain tissue (Figs 9.49, 9.50). In some cases a well-defined cavity does not form; instead, there is a ‘moth-eaten’ appearance to the area of encephalomalacia.

MICROSCOPIC APPEARANCES

Subacute infarction (approximately 5–30 days)

Neuronal eosinophilia may persist at this stage. Variable degrees of neutrophil infiltration are evident, often adjacent to necrotic microvessels (‘diapedesis’). Early microglial activation and the subsequent formation of foamy macrophages are responses to the tissue damage; the macrophages include many transformed monocytes that have moved into the infarct from the circulation. Endothelial proliferation and neovascularization are found at 5–12 days, but are variable in extent and timing (Fig. 9.52).

By days 8–14, neuronal ghosts, macrophages (foamy histiocytes), and astrocytic hyperplasia/hypertrophy are prominent. Between 15 and 30 days, eosinophilic neurons have usually disappeared (assuming new infarcts have not occurred), and necrotic white matter is notable for the presence of macrophages, neuroaxonal spheroids and surrounding reactive alterations, as well as changes of early wallerian degeneration within non-infarcted white matter.

Chronic infarction (weeks to months or years)

Foamy macrophages, often containing hemosiderin (if the infarct had a significant hemorrhagic component), may persist over many months, often as long as the patient lives. Thin-walled blood vessels pass through the cystic cavity. Abundant reactive astrocytes (often with gemistocytic morphology) encircle the infarct. In large cortical infarcts, there is a characteristic pattern of relative preservation of the molecular layer (lamina I), which contains abundant reactive astrocytes (Fig. 9.53). Residual neurons and axons in and around the infarct may become encrusted with iron or calcium (Fig. 9.54). Very rarely, thrombosed vessels adjacent to the infarct are found. The cellular and tissue events in the evolution of an infarct are shown diagrammatically in Figure 9.55. Depending upon the size of the infarct, wallerian degeneration may be noted in the descending (corticospinal) tracts, especially if a cerebral infarct involves a large region of motor cortex or underlying white matter, including the internal capsule (Fig. 9.49).

INFARCTS CAUSED BY (THROMBOEMBOLIC) OCCLUSION OF LARGE ARTERIES

The territories supplied by the major cerebral arteries are illustrated in Figure 9.56. If a destructive lesion corresponds to one of these discrete regions, its etiology is likely to be ischemic, resulting from occlusion of a major cerebral artery (Fig. 9.57). If a destructive lesion appears between two major arterial territories, it is likely to represent a watershed/borderzone infarct (see Chapter 8). Infarcts resulting from thromboembolic occlusion of the ICA resemble (in size and distribution) those caused by MCA thrombosis, though the ACA territory may also be involved (Fig. 9.58). Anatomic territories supplied by branches of the vertebrobasilar system are more variable. An example of an extensive brainstem infarct, which is secondary to basilar artery thrombosis (Fig. 9.59), contrasts with a smaller well-delineated infarct resulting from occlusion of the vertebral artery (Fig. 9.60).

SPINAL CORD INFARCTION

Infarction of the spinal cord is much less frequent than infarction in the brain. Atherosclerosis of the spinal arteries occurs only rarely, and atherosclerotic plaques in the aorta tend not to occlude the ostia of arteries that supply the cord (Fig. 9.61).

Spinal cord infarction is caused by:

image Embolization of:

image Severe hypotension (e.g. during a complicated surgical procedure or secondary to trauma).

image Decompression sickness.

image Pathologic lesions in the aorta (or treatment of same):

image Venous occlusion, in association with septicemia or metastatic carcinoma, which predisposes to thrombosis.

image Foix–Alajouanine syndrome.

image Trauma (multifactorial etiology).

MICROSCOPIC APPEARANCES

The histologic features of spinal cord infarcts appear and evolve identically to those of brain infarcts (see above). Infarcts in the distribution of the anterior spinal artery are most common and affect the anterior gray matter and adjacent white matter tracts (Fig. 9.62). Infarction resulting from hypotension preferentially affects the anterior zones of the cord and in mild cases may target anterior horn motor neurons, resulting in their loss and a limited astrocytic gliosis. The most vulnerable watershed zone is around the level of T4.

FOIX–ALAJOUANINE SYNDROME (ANGIODYSGENETIC MYELOMALACIA)

This very rare spinal cord vascular malformation usually presents in middle-aged men. Patients develop a progressive myelopathy characterized by an areflexic paraparesis, sensory disturbances, and bladder, bowel, and sexual dysfunction. The lesion, an arteriovenous fistula, is probably congenital, despite becoming symptomatic after several decades. Progressive vascular stenosis and thrombosis, with resultant infarction and vascular steal of blood from viable spinal cord tissue, produce the symptoms and signs.

The surfaces of the caudal and less often rostral cord are covered by tortuous, relatively large caliber blood vessels. By histopathologic examination, these vessels have thickened fibrotic walls lacking an elastic lamina. The cord may show focal atrophy. Zones of necrotic cord are surrounded by small caliber thick-walled tortuous vessels, some of which may become mineralized (Fig. 9.63). Areas of necrosis contain lipid-laden macrophages and are surrounded by astrogliosis. Occasionally, perivascular lymphocytes are seen, though the appearances are not those of vasculitis.

WATERSHED OR BORDERZONE INFARCTS

These usually occur in elderly individuals with significant atherosclerosis that experience one or more episodes of prolonged hypotension and reduced CNS perfusion (e.g. intraoperatively, while under general anesthesia, or after cardiac arrest). Watershed infarcts are also a complication of markedly increased intracranial pressure, especially after head injury. The infarcts are usually wedge-shaped, with their base at the pial surface. Infarction may be symmetrical within the cerebral hemispheres and focally hemorrhagic (an appearance attributed to reperfusion of necrotic tissue) (Fig. 9.64).

LACUNAR INFARCTS (LACUNES)

A lacunar infarct is small (≤1.0 cm across its maximal dimension) and often due to microvascular disease (Fig. 9.65), but it can also be embolic. Lacunar infarcts occur in regions where hypertensive microvascular disease is most common (basal ganglia, pons, internal capsule).

Lacunar infarcts may be an incidental finding at necropsy, but can produce a range of focal neurologic deficits, which depend on the region in which the infarct occurs, for example:

REFERENCES

General

Balami, J.S., Chen, R-L, Grunwald, I.Q., et al. Neurological complications of acute ischemic stroke. Lancet Neurol.. 2011;10:357–371.

Barnett, H.J.M. Forty years of progress in stroke. Stroke.. 2010;41:1068–1072.

Batjer, H.H. Cerebrovascular disease. Philadelphia: Lippincott-Raven, 1997;1276.

Caplan, L.R. Stroke thrombolysis – growing pains. Mayo Clin Proc.. 1997;72:1090–1092.

Caplan, L.R., Arenillas, J., Cramer, S.C., et al. Stroke-related translational research. Arch Neurol.. 2011;68(9):1110–1123.

Carmichael, S.T. Cellular and molecular mechanisms of neural repair after stroke: Making waves. Ann Neurol.. 2006;59:735–742.

Demaerschalk, B.M., Hwang, H-M, Leung, G. US cost of ischemic stroke: A systematic literature review. Am J Manag Care.. 2010;16:525–533.

Fisher, M. Clinical atlas of cerebrovascular disorders. London: Mosby-Wolfe; 1994.

Hachinski, V., Norris, J.W. The acute stroke. Philadelphia: FA Davis; 1985.

Jickling, G.C., Sharp, FR. Blood biomarkers of ischemic stroke. Neurotherapeutics.. 2011;8:349–360.

Marsh, J.D., Keyrouz, S.G. Stroke prevention and treatment. J Am Coll Cardiol.. 2010;56:683–691.

Mohr, J.P., Wolf, P.A., Grotta, J.C., et al. Stroke. Pathophysiology, diagnosis, and management, 5th ed., Philadelphia: Elsevier Saunders, 2011.

Saver, J.L. Proposal for a universal definition of cerebral infarction. Stroke.. 2008;39:3110–3115.

Sierra, C., Coca, A., Schiffrin, E.L. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep.. 2011;13:200–207.

Stehbens, W.E. Pathology of the cerebral blood vessels. St Louis: Mosby; 1972.

Vinters, H.V. Cerebrovascular disease – practical issues in surgical and autopsy pathology. Curr Top Pathol.. 2001;95:51–99.

Whisnant, J.P., Wiebers, D.O., O’Fallon, W.M., et al. A population-based model of risk factors for ischemic stroke: Rochester, Minnesota. Neurology.. 1996;47:1420–1428.

Atherosclerosis and atheroemboli

Adraktas, D.D., Brasic, N., Furtado, A.D., et al. Carotid atherosclerosis does not predict coronary, vertebral, or aortic atherosclerosis in patients with acute stroke symptoms. Stroke.. 2010;41:1604–1609.

Barnett, H.J.M., Gunton, R.W., Eliasziw, M., et al. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA.. 2000;283:1429–1436.

Fisher, C.M., Gore, I., Okabe, N., et al. Atherosclerosis of the carotid and vertebral arteries – extracranial and intracranial. J Neuropathol Exp Neurol.. 1965;24:455–476.

Masuda, J., Yutani, C., Ogata, J., et al. Atheromatous embolism in the brain: A clinicopathologic analysis of 15 autopsy cases. Neurology.. 1994;44:1231–1237.

Ogata, J., Masuda, J., Yutani, C., et al. Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry.. 1994;57:17–21.

Ogata, J., Yamanishi, H., Ishibashi-Ueda, H. Review: Role of cerebral vessels in ischemic injury of the brain. Neuropathol Appl Neurobiol.. 2011;37:40–55.

Ogata, J., Yutani, C., Otsubo, R., et al. Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol.. 2008;63:770–781.

Resch, J.A., Okabe, N., Loewenson, R.B., et al. Pattern of vessel involvement in cerebral atherosclerosis. J Atheroscler Res.. 1969;9:239–250.

Ross, R. Atherosclerosis – an inflammatory disease. N Engl J Med.. 1999;340:115–126.

Torvik, A., Jorgensen, L. Thrombotic and embolic occlusions of the carotid arteries in an autopsy material. Part 1. Prevalence, location and associated diseases. J Neurol Sci.. 1964;1:24–39.

Torvik, A., Jorgensen, L. Thrombotic and embolic occlusions of the carotid arteries in an autopsy series. Part 2. Cerebral lesions and clinical course. J Neurol Sci. 1966;3:410–432.

Yasaka, M., Yamaguchi, T., Shichiri, M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke.. 1993;24:206–211.

Fibromuscular dysplasia and moyamoya disease

Dusick, J.R., Gonzalez, N.R., Martin, N.A. Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: A review of 63 procedures. Neurosurgery.. 2010;68:34–43.

Furie, D.M., Tien, R.D. Fibromuscular dysplasia of arteries of the head and neck: Imaging findings. AJR Am J Roentgenol.. 1994;162:1205–1209.

Gosalakkal, J.A. Moyamoya disease: A review. Neurol India.. 2002;50:6–10.

Ikeda, E., Hosoda, Y. Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: cerebrovascular Moyamoya disease. Clin Neuropathol.. 1993;12:44–48.

Masuda, J., Ogata, J., Yutani, C. Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in Moyamoya disease. Stroke.. 1993;24:1960–1967.

Schievink, W.I., Bjornsson, J., Piepgras, D.G. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan’s syndrome and bilateral carotid artery dissections. Stroke.. 1994;25:2492–2496.

Slavin, R.E., Saeki, K., Bhagavan, B., et al. Segmental arterial mediolysis: A precursor to fibromuscular dysplasia? Mod Pathol.. 1995;8:287–294.

Touze, E., Oppenheim, C., Trystram, D., et al. Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke.. 2010;5:296–305.

Arterial dissection

Caplan, L.R., Zarins, C.K., Hemmati, M. Spontaneous dissection of the extracranial vertebral arteries. Stroke.. 1985;16:1030–1038.

Farrell, M.A., Gilbert, J.J., Kaufmann, J.C.E. Fatal intracranial arterial dissection: clinical pathological correlation. J Neurol Neurosurg Psychiatry.. 1985;48:111–121.

Ferro, P., Bonafe, A., Arrue, P., et al. Dissection of intracranial arteries – Ten cases. J Neuroradiol.. 1996;23:139–148.

Hart, R.G. Vertebral artery dissection. Neurology.. 1988;38:987–989.

Hart, R.G., Easton, J.D. Dissections. Stroke.. 1985;16:925–927.

Karacagil, S., Hardemark, H.G., Bergqvist, D. Spontaneous internal carotid artery dissection – Review. Int Angiol.. 1996;15:291–294.

Krings, T., Choi, I-S. The many faces of intracranial arterial dissections. Interventional Neuroradiology.. 2010;16:151–160.

Vasculitis/angiitis

Anders, K.H., Wang, Z.Z., Kornfeld, M., et al. Giant cell arteritis in association with cerebral amyloid angiopathy: Immunohistochemical and molecular studies. Hum Pathol.. 1997;28:1237–1246.

Ghanchi, F.D., Dutton, G.N. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol.. 1997;42:99–123.

Hajj-Ali, R.A., Calabrese, L.H. Central nervous system vasculitis. Curr Opin Rheumatol.. 2009;21:10–18.

Ho, M.G., Chai, W., Vinters, H.V., et al. Unilateral hemispheric primary angiitis of the central nervous system. J Neurol.. 2011;258:1714–1716.

Gordon, L.K., Levin, L.A. Visual loss in giant cell arteritis. JAMA.. 1998;280:385–386.

Hayreh, S.S., Podhajsky, P.A., Raman, R., et al. Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol.. 1997;123:285–296.

Rhodes, R.H., Madelaire, N.C., Petrelli, M., et al. Primary angiitis and angiopathy of the central nervous system and their relationship to systemic giant cell arteritis. Arch Pathol Lab Med.. 1995;119:334–339.

Rigby, H., Easton, A., Bhan, V. Amyloid beta-related angiitis of the central nervous system: Report of 3 cases. Can J Neurol Sci.. 2011;38:626–630.

Salvarini, C., Brown, R.D., Jr., Calamia, K.T., et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol.. 2007;62:442–451.

Scolding, N.J., Joseph, F., Kirby, P.A., et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain. 2005;128:500–515.

Vinters, H.V. Inflammation complicates an ‘age-related’ cerebral microangiopathy. Can J Neurol Sci.. 2011;38:543–544.

Microvascular disease (including familial forms and those associated with dementia)

Brulin, P., Godfraind, C., Leteurtre, E., et al. Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications. Acta Neuropathol (Berl).. 2002;104:241–248.

Chabriat, H., Joutel, A., Dichgans, M., et al. CADASIL. Lancet Neurol.. 2009;8:643–653.

Fisher, C.M. Binswanger’s encephalopathy: a review. J Neurol.. 1989;236:65–79.

Greenberg, B.M. The neurologic manifestations of systemic lupus erythematosus. Neurologist.. 2009;15:115–121.

Hachinski, V., Iadecola, C., Petersen, R.C., et al. National Institute of Neurological Disorders and Stroke – Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke.. 2006;37:2220–2241.

Hara, K., Shiga, A., Fukutake, T., et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med.. 2009;360:1729–1739.

Jen, J., Cohen, A.H., Yue, Q., et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology.. 1997;49:1322–1330.

Kalimo, H., Miao, Q., Tikka, S., et al. CADASIL: the most common hereditary subcortical vascular dementia. Future Neurol.. 2008;3:683–704.

Lammie, G.A. Hypertensive cerebral small vessel disease and stroke. Brain Pathol.. 2002;12:358–370.

Lanfranconi, S., Markus, H.S. COL4A1 mutations as a monogenic cause of cerebral small vessel disease. A systematic review. Stroke.. 2010;41:e513–e518.

Selnes, O.A., Vinters, H.V. Vascular cognitive impairment. Nat Clin Pract Neurol.. 2006;2:538–547.

Tanoi, Y., Okeda, R., Budka, H. Binswanger’s encephalopathy: serial sections and morphometry of the cerebral arteries. Acta Neuropathol (Berl).. 2000;100:347–355.

Verbeek M.M., de Waal R.M.W., Vinters H.V., eds. Cerebral amyloid angiopathy in Alzheimer’s disease and related disorders. Dordrecht: Kluwer Academic, 2000.

Vinters, H.V., Ellis, W.G., Zarow, C., et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol.. 2000;59:931–945.

Infarcts (major vessel territory, watershed, lacunar, spinal cord, etc.)

Bogousslavsky, J., Barnett, H.J.M., Fox, A.J., et al. Atherosclerotic disease of the middle cerebral artery. Stroke.. 1986;17:1112–1120.

Castaigne, P., Lhermitte, F., Gautier, J.C., et al. Arterial occlusions in the vertebro-basilar system. A study of 44 patients with post-mortem data. Brain. 1973;96:133–154.

Cheshire, W.P., Santos, C.C., Massey, E.W., et al. Spinal cord infarction: Etiology and outcome. Neurology.. 1996;47:321–330.

Chuaqui, R., Tapia, J. Histologic assessment of the age of recent brain infarcts in man. J Neuropathol Exp Neurol.. 1993;52:481–489.

Fisher, C.M. Lacunes: Small, deep cerebral infarcts. Neurology.. 1965;15:774–784.

Gacs, G., Fox, A.J., Barnett, H.J.M., et al. Occurrence and mechanisms of occlusion of the anterior cerebral artery. Stroke.. 1983;14:952–959.

Gan, R., Sacco, R.L., Kargman, D.E., et al. Testing the validity of the lacunar hypothesis: The Northern Manhattan Stroke Study experience. Neurology.. 1997;48:1204–1211.

Helgason, C., Caplan, L.R., Goodwin, J., et al. Anterior choroidal artery-territory infarction. Report of cases and review. Arch Neurol.. 1986;43:681–686.

Kubik, C.S., Adams, R.D. Occlusion of the basilar artery – a clinical and pathological study. Brain.. 1946;69:73–121.

Torvik, A. The pathogenesis of watershed infarcts in the brain. Stroke.. 1984;15:221–223.

Share this: